Editorial: Neuroblastoma: Signal Crosstalk and Future Insight Into Clinical Trials

• Kiyohiro Ando,
• Takaomi Sanda,
• Yusuke Suenaga,
• Tao Liu,
• Tao Liu

Affiliations

Kiyohiro Ando

Research Institute for Clinical Oncology, Saitama Cancer Center, Saitama, Japan

Takaomi Sanda

Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore

Yusuke Suenaga

Department of Molecular Carcinogenesis, Chiba Cancer Center Research Institute, Chiba, Japan

Tao Liu

School of Women’s and Children’s Health, University of New South Wales Sydney, Sydney, NSW, Australia

Tao Liu

Children’s Cancer Institute, Sydney, NSW, Australia